Pioneering Pain-free Solutions
We leverage the power of medical technology to develop transformative, accurate solutions that improve quality of life.
We are on a mission to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life.
Our Technology
Revolutionizing Drug Testing Through Fingerprint Sweat Analysis
Our innovative Intelligent Fingerprinting Drug Testing Solution detects commonly abused drugs via sweat from the fingertips. The system’s ease of use and portability make it a convenient solution for reliable drug screening and identification of potential misuse within the 16-24 hours before testing.
Fingerprint DRUG Testing
A Dignified Approach to Drug Testing
Our Intelligent Fingerprinting Drug Screening System tests fingertip sweat for recent drug use, including cannabis, cocaine, opiates, and methamphetamine. Samples are collected in less than one minute and results displayed in less than ten minutes.
INVESTOR RELATIONS
Transforming Testing Solutions Through Med Tech Innovation
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. Its Intelligent Fingerprinting Drug Testing Solution is currently being utilized across multiple industries, With recent FDA 510(k) submission in December of 2024 and entry into the US market planned for 2025, INBS is capitalizing on the rapidly growing drug screening products market.
THE BIOSENSOR PLATFORM
A Platform for Multiple Diagnostic Tests
The biosensor platform is a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners.
Intelligent Bio Solutions News
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
NEW YORK, July 16, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global distribution
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
NEW YORK, July 15, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition
Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
Data shows excretion of codeine in fingerprint sweat INBS’ System is viable option for non-invasive diagnostic testing NEW YORK, July 17, 2025 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”),